Walleye Capital’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Walleye Capital’s Portfolio DPLO Stock Details DPLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-154,121	Closed	-$616K	–	2038
2019 Q4	$616K	Buy	154,121 +120,921	+364%	+$568K	0.04%	588
2019 Q3	$163K	Buy	33,200 +1,200	+4%	+$6.71K	0.01%	1277
2019 Q2	$195K	Buy	32,000 +20,600	+181%	+$109K	0.02%	983
2019 Q1	$66K	Buy	+11,400	New	+$118K	0.01%	1152

Other funds holding DPLO

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Walleye Capital's DPLO Position: Q1 2020 in Review

Walleye Capital sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2020, closing a stake of 154,121 shares — an estimated $616K sold.

Walleye Capital first reported a position in DPLO in Q1 2019 and held it in 4 quarters. The position peaked at $616K in Q4 2019. 1 fund tracked by Wall St. Rank holds DPLO as of Q1 2020.

Walleye Capital reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2020 after selling out during the quarter.
Walleye Capital sold 154,121 DIPLOMAT PHARMACY, INC. shares in Q1 2020, an estimated $616K.
Walleye Capital first reported a position in DIPLOMAT PHARMACY, INC. in Q1 2019 and held it in 4 quarters.
Walleye Capital's DIPLOMAT PHARMACY, INC. position peaked at $616K in Q4 2019.
1 fund tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2020.

Based on Walleye Capital's 13F filing for Q1 2020, filed 15 May 2020.